Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 104.87
+2.04 (1.98%)
At close: Jul 27, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 400.17 million as of July 28, 2026. Its market cap has increased by 179.78% in one year.
Market Cap
400.17M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
104.87
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 400.17M, an increase of 489.31%. That is a compound annual growth rate of 28.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 400.17M | 216.17% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ANG Lifesciences India | 466.57M |
| Shelter Pharma | 455.77M |
| Vista Pharmaceuticals | 438.25M |
| Mangalam Drugs & Organics | 435.28M |
| Rajnish Wellness | 426.45M |
| Sandu Pharmaceuticals | 379.68M |
| JFL Life Sciences | 371.20M |
| Murae Organisor | 353.20M |